Português

Inglês

Home | Site Map | Add to Favorites Link | Send page to a Friend | Contact us

All Content

Revistas e artigos de divulgação

Brazilian drug shows potential against tuberculosis and cancer- August 2012

In an article recently published in Infectious Agents and Cancer, Brazilian and North American researchers showed that a drug developed in Brazil, called P-MAPA, is able to activate certain immune system receptors and helps fight tuberculosis and bladder cancer.

Brazilian drug improves the immunity of dogs with leishmaniasis

A study published recently in the journal Acta Tropica has shown that P-MAPA, a drug developed in Brazil has shown effectiveness in improving the clinical state and immunity of dogs with symptoms of leishmaniasis

Sala de imprensa

Brazil-based research network announces the effectiveness of a new antiviral

Farmabrasilis announces the publication of the effectiveness of P-MAPA, a new immunomodulator, for antiviral applications, in the journal Antiviral Research. This research was conducted in collaboration with Dr. Brian Gowen at the Institute for Antiviral Research of Utah State University and was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Relatórios Clínicos

Clinical Trial - Phase I

Objectives: Primary: To determine the toxicity and side effects, of P-MAPA immunomodulator in HIV + individuals. Secondary: To determine the local and systemic effect, if any, of P-MAPA in the individuals.To determine the effect, if any, in the white blood cell count.

Projetos de utilização clínica

The Farmabrasilis Infectious Diseases Proposal :

A new, powerful, affordable immunomodulator and a strategy for large-scale deployment

Notícias

Farmabrasilis in XXXII Congress of the Brazilian Society for Immunology-2008

Farmabrasilis in the International Conference of ICS-UNIDO- Trieste, Italy, 3 to 5 july 2008

Farmabrasilis in the 2nd World Conference on Magic Bullets - Ehrlich II - Nürnberg -Germany 2008

Farmabrasilis in the 3rd Stop TB Partners Forum -Rio 2009

Farmabrasilis announces the effectiveness of a new antiviral

[ First ] [ Previous ] [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] [ 8 ] [ 9 ] [ Next ] [ Last ]

Lógica Digital

Privacy Policy | Legal | copyright@2.006-farmabrasilis- all rights reserved